Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice - Enhanced disease severity by impaired inducible nitric oxide synthase induction

Citation
U. Eriksson et al., Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice - Enhanced disease severity by impaired inducible nitric oxide synthase induction, CIRCULATION, 103(1), 2001, pp. 18-21
Citations number
10
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
103
Issue
1
Year of publication
2001
Pages
18 - 21
Database
ISI
SICI code
0009-7322(20010102)103:1<18:LAMIIR>2.0.ZU;2-W
Abstract
Background-Interferon-gamma (IFN-gamma) is an essential cytokine in the reg ulation of inflammatory responses in autoimmune diseases. Little is known a bout its role in inflammatory heart disease. Methods and Results-We showed that IFN-gamma receptor-deficient mice (IFN-g ammaR(-/-)) on a BALB/c background immunized with a peptide derived from ca rdiac alpha -myosin heavy chain develop severe myocarditis with high mortal ity. Although myocarditis subsided in wild-type mice after 3 weeks, IFN-gam maR(-/-) mice showed persistent disease. The persistent inflammation was ac companied by vigorous in vitro CD4 T-cell responses and impaired inducible nitric oxide synthase expression, together with evidence of impaired nitric oxide production in IFN-gammaR(-/-) hearts. Treatment of wild-type mice wi th the nitric oxide synthetase inhibitor N-nitro-L-arginine-methyl-ester en hanced in vitro CD4 T-cell proliferation and prevented healing of myocardit is. Conclusions-Our data provide evidence that IFN-gamma protects mice fi om le thal autoimmune myocarditis by inducing the expression of inducible nitric oxide synthase followed by the downregulation of T-cell responses.